0001213900-21-027991.txt : 20210519
0001213900-21-027991.hdr.sgml : 20210519
20210519174032
ACCESSION NUMBER: 0001213900-21-027991
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210517
FILED AS OF DATE: 20210519
DATE AS OF CHANGE: 20210519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kaplan Myron
CENTRAL INDEX KEY: 0001672645
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34673
FILM NUMBER: 21941466
MAIL ADDRESS:
STREET 1: C/O KLEINBERG, KAPLAN, WOLFF & COHEN, PC
STREET 2: 551 FIFTH AVENUE, 18TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10176
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CorMedix Inc.
CENTRAL INDEX KEY: 0001410098
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4200
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 908-517-9500
MAIL ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4200
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
4
1
ownership.xml
X0306
4
2021-05-17
0
0001410098
CorMedix Inc.
CRMD
0001672645
Kaplan Myron
C/O CORMEDIX INC., 300 CONNELL DRIVE,
SUITE 4200
BERKELEY HEIGHTS
NJ
07922
1
0
0
0
Common Stock
2021-05-17
4
P
0
15000
6.0318
A
165034
D
Stock Option (Right to Buy Common Stock)
8.32
2031-01-11
Common Stock
30000
30000
D
Stock Option (Right to Buy Common Stock)
5.63
2030-02-25
Common Stock
15000
15000
D
Stock Option (Right to Buy Common Stock)
8.3
2029-01-10
Common Stock
15000
15000
D
Stock Option (Right to Buy Common Stock)
2.85
2028-02-16
Common Stock
8000
8000
D
Stock Option (Right to Buy Common Stock)
11.2
2027-02-21
Common Stock
8000
8000
D
Stock Option (Right to Buy Common Stock)
21.4
2026-04-28
Common Stock
10000
10000
D
This transaction was executed in multiple trades at prices ranging from $5.98 to $6.09. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
These options were granted on 02/25/2020. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board.
These options were granted on 01/10/2019. These options are fully vested.
These options were granted on 02/16/2018. These options are fully vested.
These options were granted on 02/21/2017. These options are fully vested.
These options were granted on 4/28/2016. These options are fully vested.
The Issuer effected a 1-for-5 reverse stock split of its common stock on March 26, 2019. All share and per share exercise price amounts shown in this Form 4 have been adjusted to reflect the reverse stock split.
/s/ Myron Kaplan
2021-05-19